Generalizability of the Necrotizing Enterocolitis Surgery Trial (NEST) to Eligible, Non-Randomized Infants

Monday, April 25, 2022

9:15 AM – 9:30 AM US MT

Location: Convention Center: Mile High Ballroom 2AB

CE: Enduring CME: 0.25

Publication Number: 3170.5

Matthew Rysavy, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, United States; Barry S. Eggleston, RTI International, Mebane, NC, United States; Issa Dahabreh, Harvard T.H. Chan School of Public Health, Boston, MA, United States; Jon Tyson, UT Health, houston, TX, United States; Ravi M. Patel, Emory University and Children's Healthcare of Atlanta, Atlanta, GA, United States; Kristi L. Watterberg, University of New Mexico School of Medicine, Albuquerque, NM, United States; Rachel G. Greenberg, Duke Clinical Research Institute, Durham, NC, United States; Claudia Pedroza, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, United States; David K. Stevenson, Stanford University School of Medicine, Stanford, CA, United States; Barbara J. Stoll, China Medical Board, Atlanta, GA, United States; Kevin P. Lally, McGovern Medical School at UTHouston, Houston, TX, United States; Abhik Das, RTI International, North Potomac, MD, United States; Martin L. Blakely, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN, United States

Presenting Author(s)

Matthew A. Rysavy, MD, PhD
Assistant Professor of Pediatrics
McGovern Medical School at the University of Texas Health Science Center at Houston
Houston, Texas, United States

Full Presentation

Participants should be aware of the following financial/non-financial relationships:

Matthew A. Rysavy, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Barry S. Eggleston, M.S.: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Issa Dahabreh, MD, ScD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Jon Tyson, MD, MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Ravi M. Patel, MD, MSc: ● Infant Bacterial Therapeutics / Premier Research (Currently Ongoing) (Products/Services: Consultant).

Kristi L. Watterberg, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Rachel G. Greenberg, MD, MB, MHS: ● Tellus Therapeutics (Currently Ongoing) (Products/Services: Consultant).

Claudia Pedroza, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

David K. Stevenson, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Barbara J. Stoll, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Kevin P. Lally, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Abhik Das, Ph.D.: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Martin L. Blakely, Blakely, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.